Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

JM Integrated Health vs Wisp

JM Integrated Health
Graded #427

Lower grade

vs+8.500000000000007
Wisp
Graded #243

Higher grade

The verdict

Wisp takes it — 64.4/100 to 55.9/100.

Wisp grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Wisp (hellowisp.com) is a US telehealth provider whose weight care vertical offers brand-name Wegovy, Zepbound, and Saxenda alongside a compounded sublingual semaglutide drops formulation at $225/month.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueWisp +5
45
50
Dose & formulationWisp +23
53
76
Clinical oversightJM Integrated Health +7
89
82
Labs & monitoringEven
53
53
FulfillmentWisp +10
56
66
Contract termsWisp +35
20
55
JM Integrated Health · left barWisp · right bar

The numbers

MetricJM Integrated HealthWisp
WeighScore55.9/10064.4/100
GradeCC
Scorecard rank#427#243
SemaglutideNot disclosed$225/mo (compounded oral)
TirzepatideNot disclosedNot disclosed
Coverage6 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
JM Integrated Health

Graded #427 · C

Strengths

  • Transparent cash-pay pricing — $149 enrollment plus $99/month, no hidden fees
  • Medication cost is billed separately by the pharmacy, so the program fee isn't inflated by drug markup
  • Six states clearly listed (TX, VT, NM, AZ, WA, NV)
  • Named provider — John Meyer, FNP-C, board-certified, 10+ years' experience
  • Publishes the FDA compounded-medication disclaimer

Where it loses points

  • 503A pharmacy partner not named publicly
  • Single-provider practice — enrollment is capacity-limited
  • Only six states served, vs nationwide competitors
  • Total monthly cost is the program fee plus a separate pharmacy bill, not one all-in price
  • No LegitScript certification displayed
Wisp

Graded #243 · C

Strengths

  • Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
  • LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
  • Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary

Where it loses points

  • The $99/mo tirzepatide figure is a consultation-and-care subscription, not the medication: Zepbound is filled at a pharmacy of your choice at its own cost, which Wisp does not publish
  • The compounded semaglutide option is sublingual drops, which Wisp itself describes as less effective than injection
  • Brand-name access is a prescription, not a dispensed product, so the drug cost is outside anything quoted here

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard